Our multi-omics analysis revealed that PSME2 exhibits frequent copy number variations (CNVs) in breast cancer, and its variation status is significantly correlated with mRNA expression levels: it is markedly upregulated in samples with CNV amplification and significantly downregulated in samples with deletion (P < 0.01). The gene discussed is PSME2; the disease is breast carcinoma.